Nov. 29--NEW HAVEN -- In the little laboratory she built from scratch, Sarah
Crawford is working on a Christmas fern miracle.
Not that she'd ever use the word "miracle" to describe the cancer research she's
been conducting at Southern Connecticut State University for the past 17 years.
She's much too measured for that. Besides, she says the media seems to tout a
new cure for cancer every other week.
Yet, it's undeniable what Crawford has accomplished outside the realm of high
profile, big money cancer research. Not only is she rethinking basic assumptions
about the disease, she recently was granted a patent for a Christmas fern
extract that shows potential for treating brain cancers.
The extract, used in a cocktail with the chemotherapy drug carmustine and
curcumin, the active ingredient in turmeric, killed nearly half of the cancer
cells in animal tumors during pre-clinical testing. Crawford said that within a
year, she'll be ready to approach pharmaceutical companies and large research
labs about doing a human study.
Not bad for a college professor without major funding or a staff to write grant
"There needs to be a place for the individual researcher in science," Crawford
said. "You have to be able to close a door, sit down and think something
through. But you also have to be willing to do without the money and be able to
In her case, that means going to state parks on the weekends to gather Christmas
ferns and using chicken eggs to test tumor treatments.
Actually, it took a fair bit of gumption just to envision her lab at SCSU in the
first place. She'd come to the university in 1993 to teach genetics, raise her
two young daughters and figure out what sort of cancer research she'd like to do
But then she got to thinking.
"I walked into this sort of broken down room, and the thought occurred to me,
'You could have your own lab right here. Do the research you want to do.'" The
lab opened -- with no fanfare -- in 1996.
Her focus, she decided, would be on drug resistance. Why don't certain cancers
respond well to treatment? Is it because we treat cancer only as an acute
disease rather than a systemic one?
Crawford began studying the use of aspirin and anti-inflammatory drugs on
tumors. She found that solid tumors responded slowly to large amounts of
Then she broadened her approach and looked at plant products with high
antioxidant activity. That's how she arrived at Christmas ferns.
"They're primitive plants," Crawford said. "They have a very different
biochemical composition. These plants were some of the first to evolve, and
they're very successful."
She and her students started very simply, grinding up ferns and looking for the
key ingredients. They discovered that in concert with curcumin and carmustine,
the ferns produced far better cancer-fighting results on tumors than when any of
the three substances was used alone.
Crawford applied for a patent more than six years ago; she now shares it with
Erin Boisvert, one of her former students.
Of course, this is only the beginning of the process for Crawford. She has plans
to tinker with the drug cocktail and test it on pancreatic tumors.
"I always temper my excitement with reality," she said. "I'm not going to rest
until we, as a research community, are able to effectively deal with this
disease. We have to find a cure."
Crawford's motivation stems in part from a childhood experience.
At the age of 9, she spent two weeks in the children's ward of a New York City
hospital. It was Christmas time, and Crawford met children dealing with cancer,
kidney disease and other dire ailments. One child died while Crawford was on the
"It was one of the major experiences of my childhood. It changed my life,"
Crawford said. "I'll never forget walking out of there and knowing I would be
studying disease for the rest of my life."
By now, more than 100 students have come through Crawford's little lab. In 2015,
she'll move to a brand new building on campus, the Academic and Laboratory
But don't expect her to take on expensive research habits.
"It certainly has its place, but that focus on funding keeps you thinking inside
the box," Crawford said.
Call Jim Shelton at 203-789-5664. Have questions, feedback or ideas about our
coverage? Connect directly with the editors of the New Haven Register at
(c)2013 the New Haven Register (New Haven, Conn.)
Visit the New Haven Register (New Haven, Conn.) at www.nhregister.com
Distributed by MCT Information Services